ReviewPublished 31 March 2026Revisiting old drugs and drug combinations for polycythemia vera and related neoplasmsGökhan Mergen · Hans C. HasselbalchFrontiers in Hematologydoi 10.3389/frhem.2026.1749376
ReviewPublished 8 January 2026Targeting the JAK2V617F mutant hematopoietic microenvironment in myeloproliferative neoplasmAmar YewareFrontiers in Hematologydoi 10.3389/frhem.2025.1694867